Results 81 to 90 of about 5,026 (202)
ABSTRACT Introduction Chronic inflammation is a unique contributor to cardiovascular disease (CVD) risk among people living with HIV, yet there is a lack of consensus on the predictive utility of inflammatory biomarkers in this population. We conducted a systematic review assessing the predictive value of inflammatory biomarkers for major adverse ...
Ashley Murray +10 more
wiley +1 more source
ROC-curves based on the prognostic index of inclusion suPAR, HIV status, gender, age and with (red line) or without (blue line) increased suPAR level at 1 month included in the model.
Andreas Andersen (310001) +7 more
core +1 more source
Unchanged plasma levels of the soluble urokinase plasminogen activator receptor in elective coronary artery bypass graft surgery patients and cardiopulmonary bypass use. [PDF]
Objective and designThe soluble urokinase plasminogen activator receptor (suPAR) has been recently recognized as a potential biological marker of various disease states, but the impact of a major surgical intervention on the suPAR level has not yet been ...
Waldemar Gozdzik +5 more
doaj +1 more source
By comparing plasma proteomes of young and older adults, as well as older adults with varying levels of disease burden, this study aims to identify plasma proteins at the intersection of age and disease. The identified signature points to potential candidate biomarkers of biological aging.
Juliette Tavenier +9 more
wiley +1 more source
Plasma suPAR is lowered by smoking cessation:a randomized controlled study
BACKGROUND: Soluble urokinase plasminogen activator receptor (suPAR) is a stable inflammatory biomarker. In patients, suPAR is a marker of disease presence, severity and prognosis.
Sørensen, Lars Tue +2 more
core +1 more source
suPAR as a marker of infection in acute kidney injury – a prospective observational study
Background Soluble urokinase-type plasminogen activator receptor (suPAR) has emerged as a new sepsis biomarker. It is not known whether suPAR has a role in critically ill patients with severe acute kidney injury (AKI).
Anna Hall +4 more
doaj +1 more source
ABSTRACT Medication deprescribing is a targeted strategy to reduce inappropriate polypharmacy. Patients in primary care settings have reported high willingness to discontinue medications, but this phenomenon is less well studied in hospital settings. In this explorative post hoc analysis of two previously described clinical trials, we assessed patients'
Louise Westberg Strejby Christensen +12 more
wiley +1 more source
Melatonin and the Dental Pulp: A Scoping Review
ABSTRACT Background In general medicine, melatonin is known to enhance wound healing and promote stem cell differentiation. Its potential relevance in endodontics, however, remains underexplored. Objectives This scoping review aimed to systematically assess the available evidence on the effects of melatonin (a) on dental pulp tissue and (b) on human ...
Jasmin Schäfer +2 more
wiley +1 more source
Companion Diagnostics in Clinical Therapy: Current Applications and Future Directions
Companion diagnostics use biomarker‐based assays to stratify patients for precision therapies, improving outcomes while reducing ineffective treatment and side effects. This review summarizes the evolution, regulatory landscape, clinical applications, and technological platforms of CDx, highlighting their role in biomarker‐driven precision therapy.
Yuesong Wu +9 more
wiley +1 more source
BackgroundType 2 diabetes mellitus is a major risk factor for cardiovascular disease; however, outcomes in individual patients vary. Soluble urokinase plasminogen activator receptor (suPAR) is a bone marrow–derived signaling molecule associated with ...
Salim S. Hayek +7 more
doaj +1 more source

